These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28262290)

  • 21. Left Atrial Appendage Occlusion for Stroke Prevention.
    Chanda A; Reilly JP
    Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    Safavi-Naeini P; Rasekh A
    Tex Heart Inst J; 2016 Aug; 43(4):320-3. PubMed ID: 27547142
    [No Abstract]   [Full Text] [Related]  

  • 23. Left atrial appendage exclusion: state-of-the-art.
    Cruz-Gonzalez I; Yan BP; Lam YY
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):806-13. PubMed ID: 20088009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The LAA occlusion Foxtrot: steps forward; steps back.
    Block PC
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):707-8. PubMed ID: 21433273
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous closure of the left atrial appendage: a major step forward.
    Sievert H; Bayard YL
    JACC Cardiovasc Interv; 2009 Jul; 2(7):601-2. PubMed ID: 19628180
    [No Abstract]   [Full Text] [Related]  

  • 26. Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study.
    Huang H; Liu Y; Xu Y; Wang Z; Li Y; Cao K; Zhang S; Yang Y; Yang X; Huang D; Yu B; Su X; Wu L; Huang C
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2188-2194. PubMed ID: 29122133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous left atrial appendage closure for managing thromboembolic risk in atrial fibrillation.
    Khan F; Ramirez FD; Hibbert B
    CMAJ; 2018 Oct; 190(41):E1227-E1230. PubMed ID: 30322987
    [No Abstract]   [Full Text] [Related]  

  • 28. An overview of current and emerging devices for percutaneous left atrial appendage closure.
    Chow DHF; Wong YH; Park JW; Lam YY; De Potter T; Rodés-Cabau J; Asmarats L; Sandri M; Sideris E; McCaw T; Lee RJ; Sievert H; Søndergaard L; De Backer O
    Trends Cardiovasc Med; 2019 May; 29(4):228-236. PubMed ID: 30205924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated.
    Peritz DC; Chung EH
    Cleve Clin J Med; 2015 Mar; 82(3):167-76. PubMed ID: 25932742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    Masoudi FA; Calkins H; Kavinsky CJ; Slotwiner DJ; Turi ZG; Drozda JP; Gainsley P; ; ;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):791-807. PubMed ID: 26256562
    [No Abstract]   [Full Text] [Related]  

  • 31. Left atrial appendage occlusion: opportunities and challenges.
    Holmes DR; Lakkireddy DR; Whitlock RP; Waksman R; Mack MJ
    J Am Coll Cardiol; 2014 Feb; 63(4):291-8. PubMed ID: 24076495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left Atrial Appendage Occlusion for The Unmet Clinical Needs of Stroke Prevention in Nonvalvular Atrial Fibrillation.
    Holmes DR; Alkhouli M; Reddy V
    Mayo Clin Proc; 2019 May; 94(5):864-874. PubMed ID: 30962008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.
    Bergmann MW
    Trends Cardiovasc Med; 2017 Aug; 27(6):435-446. PubMed ID: 28461140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left atrial appendage closure with Amplatzer Cardiac Plug for prevention of stroke in atrial fibrillation: in-vivo imaging.
    Leithäuser B; Broemel T; Park JW
    J Cardiovasc Med (Hagerstown); 2011 Mar; 12(3):209-11. PubMed ID: 20479656
    [No Abstract]   [Full Text] [Related]  

  • 35. Transcatheter closure of the left atrial appendage: A focused update on the Watchman closure device.
    Khalili H; Mansi IA; Hanzel GS; Banerjee S
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):E28-E34. PubMed ID: 28471004
    [No Abstract]   [Full Text] [Related]  

  • 36. The WATCHMAN Left Atrial Appendage Closure Device: Technical Considerations and Procedural Approach.
    Price MJ
    Interv Cardiol Clin; 2018 Apr; 7(2):201-212. PubMed ID: 29526288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation.
    Ussia GP; Mulè M; Cammalleri V; Scarabelli M; Barbanti M; Immè S; Mangiafico S; Marchese A; Galassi AR; Tamburino C
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):217-22. PubMed ID: 19472361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
    Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel approach to treat residual peridevice leakage after left-atrial appendage closure.
    Wunderlich N; Wilson N; Sievert H
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):313-9. PubMed ID: 23629764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial commentary: Left atrial appendage occlusion for prevention of thromboembolism in atrial fibrillation: Is it ready for first line therapy?
    Bhakta D; Sharif M
    Trends Cardiovasc Med; 2024 May; 34(4):234-235. PubMed ID: 36858290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.